These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25172140)

  • 1. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.
    Ramírez-Venegas A; Sansores RH; Quintana-Carrillo RH; Velázquez-Uncal M; Hernandez-Zenteno RJ; Sánchez-Romero C; Velazquez-Montero A; Flores-Trujillo F
    Am J Respir Crit Care Med; 2014 Nov; 190(9):996-1002. PubMed ID: 25172140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.
    Golpe R; Sanjuán López P; Cano Jiménez E; Castro Añón O; Pérez de Llano LA
    Arch Bronconeumol; 2014 Aug; 50(8):318-24. PubMed ID: 24576449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.
    Olloquequi J; Jaime S; Parra V; Cornejo-Córdova E; Valdivia G; Agustí À; Silva O R
    Respir Res; 2018 Jan; 19(1):13. PubMed ID: 29347936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoke, Biomass Exposure, and COPD Risk in the Primary Care Setting: The PUMA Study.
    Montes de Oca M; Zabert G; Moreno D; Laucho-Contreras ME; Lopez Varela MV; Surmont F
    Respir Care; 2017 Aug; 62(8):1058-1066. PubMed ID: 28559464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
    Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
    Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.
    Nishimura M; Makita H; Nagai K; Konno S; Nasuhara Y; Hasegawa M; Shimizu K; Betsuyaku T; Ito YM; Fuke S; Igarashi T; Akiyama Y; Ogura S;
    Am J Respir Crit Care Med; 2012 Jan; 185(1):44-52. PubMed ID: 22016444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women.
    Camp PG; Ramirez-Venegas A; Sansores RH; Alva LF; McDougall JE; Sin DD; Paré PD; Müller NL; Silva CI; Rojas CE; Coxson HO
    Eur Respir J; 2014 Mar; 43(3):725-34. PubMed ID: 24114962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
    Lange P; Celli B; Agustí A; Boje Jensen G; Divo M; Faner R; Guerra S; Marott JL; Martinez FD; Martinez-Camblor P; Meek P; Owen CA; Petersen H; Pinto-Plata V; Schnohr P; Sood A; Soriano JB; Tesfaigzi Y; Vestbo J
    N Engl J Med; 2015 Jul; 373(2):111-22. PubMed ID: 26154786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease in women exposed to wood stove smoke.
    Moreira MA; Barbosa MA; Jardim JR; Queiroz MC; Inácio LU
    Rev Assoc Med Bras (1992); 2013; 59(6):607-13. PubMed ID: 24211014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in FEV1 related to genetic polymorphisms (+138insA/delA and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study.
    Kaparianos A; Argyropoulou E; Efremidis G; Flordellis C; Spiropoulos K
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):705-19. PubMed ID: 20707291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass.
    Ceylan E; Kocyigit A; Gencer M; Aksoy N; Selek S
    Respir Med; 2006 Jul; 100(7):1270-6. PubMed ID: 16307872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of FEV1 decline in relatively healthy heavy smokers: implications of expressing changes in FEV1 in relative terms.
    Thomsen LH; Dirksen A; Shaker SB; Skovgaard LT; Dahlbäck M; Pedersen JH
    COPD; 2014 Feb; 11(1):96-104. PubMed ID: 24111638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative Systemic Biomarkers of Biomass Smoke-Induced Chronic Obstructive Pulmonary Disease among Women in a Rural South Indian Population.
    Vishweswaraiah S; Thimraj TA; George L; Krishnarao CS; Lokesh KS; Siddaiah JB; Larsson K; Upadhyay S; Palmberg L; Anand MP; Ganguly K
    Dis Markers; 2018; 2018():4949175. PubMed ID: 30595762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
    Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
    Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malondialdehyde and superoxide dismutase correlate with FEV(1) in patients with COPD associated with wood smoke exposure and tobacco smoking.
    Montaño M; Cisneros J; Ramírez-Venegas A; Pedraza-Chaverri J; Mercado D; Ramos C; Sansores RH
    Inhal Toxicol; 2010 Aug; 22(10):868-74. PubMed ID: 20583895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profile.
    Solleiro-Villavicencio H; Quintana-Carrillo R; Falfán-Valencia R; Vargas-Rojas MI
    Clin Immunol; 2015 Dec; 161(2):150-5. PubMed ID: 26220216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary function in first generation children of chronic obstructive pulmonary disease (COPD) patients: assessment of related predicting factors].
    Lu B; He Q; Chen Q; Huang X; Li J
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1136-9. PubMed ID: 12425829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.